Latest Ratios: P/E Ratio 38.0x · EV/EBITDA 24.2x · ROE 22.3%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $77.9B | $74.9B | $67.2B | $56.8B | $41.7B | $67.8B | $62.1B | $56.4B | $43.1B | $39.4B | $34.8B |
| Enterprise Value | $86.7B | $83.7B | $74.2B | $64.6B | $50.1B | $76.6B | $67.9B | $63.2B | $50.1B | $46.6B | $41.1B |
| P/E Ratio → | 38.01 | 36.06 | 31.79 | 41.41 | 38.20 | 60.00 | — | 36.21 | 30.19 | 26.21 | 28.31 |
| P/S Ratio | 4.84 | 4.66 | 4.27 | 3.71 | 2.94 | 5.33 | 5.27 | 4.49 | 2.94 | 2.85 | 2.64 |
| P/B Ratio | 8.05 | 7.64 | 7.64 | 7.04 | 5.75 | 9.35 | 10.01 | 6.47 | 5.36 | 5.13 | 4.99 |
| P/FCF | 40.90 | 39.32 | 36.91 | 34.71 | 38.79 | 47.80 | 45.29 | 33.41 | 30.16 | 32.26 | 29.40 |
| P/OCF | 26.38 | 25.36 | 23.87 | 23.56 | 23.33 | 32.89 | 33.38 | 23.32 | 18.94 | 18.86 | 17.93 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.20 | 4.71 | 4.22 | 3.53 | 6.02 | 5.76 | 5.03 | 3.41 | 3.37 | 3.13 |
| EV / EBITDA | 24.17 | 23.33 | 20.91 | 20.96 | 19.68 | 30.31 | 26.94 | 23.53 | 17.15 | 15.05 | 14.39 |
| EV / EBIT | 29.75 | 29.99 | 25.50 | 30.63 | 31.20 | 46.99 | 48.28 | 32.00 | 24.09 | 22.94 | 21.35 |
| EV / FCF | — | 43.93 | 40.77 | 39.49 | 46.62 | 54.00 | 49.55 | 37.38 | 35.00 | 38.08 | 34.78 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5% | 44.5% | 43.5% | 40.3% | 38.2% | 41.0% | 41.5% | 44.0% | 41.3% | 42.1% | 47.9% |
| Operating Margin | 18.1% | 18.1% | 16.6% | 14.1% | 11.3% | 13.2% | 14.5% | 15.2% | 13.5% | 15.9% | 15.3% |
| Net Profit Margin | 12.9% | 12.9% | 13.4% | 9.0% | 7.7% | 8.9% | -10.2% | 12.4% | 9.7% | 10.9% | 9.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.3% | 22.3% | 25.1% | 17.9% | 15.0% | 16.8% | -16.1% | 18.6% | 18.2% | 20.5% | 17.6% |
| ROA | 8.8% | 8.8% | 9.6% | 6.3% | 5.1% | 5.7% | -6.2% | 7.6% | 7.1% | 7.9% | 6.7% |
| ROIC | 12.7% | 12.7% | 12.4% | 10.3% | 7.6% | 9.0% | 9.3% | 9.4% | 10.0% | 11.7% | 11.3% |
| ROCE | 15.8% | 15.8% | 14.9% | 12.4% | 9.2% | 10.3% | 10.5% | 11.4% | 12.0% | 13.8% | 13.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.96 | 0.96 | 0.94 | 1.08 | 1.24 | 1.26 | 1.15 | 0.78 | 0.87 | 0.95 | 0.96 |
| Debt / EBITDA | 2.63 | 2.63 | 2.33 | 2.83 | 3.54 | 3.62 | 2.82 | 2.54 | 2.41 | 2.37 | 2.34 |
| Net Debt / Equity | — | 0.90 | 0.80 | 0.97 | 1.16 | 1.21 | 0.94 | 0.77 | 0.86 | 0.92 | 0.91 |
| Net Debt / EBITDA | 2.45 | 2.45 | 1.98 | 2.53 | 3.31 | 3.48 | 2.32 | 2.50 | 2.37 | 2.30 | 2.23 |
| Debt / FCF | — | 4.61 | 3.86 | 4.77 | 7.84 | 6.20 | 4.27 | 3.97 | 4.84 | 5.82 | 5.38 |
| Interest Coverage | 11.57 | 11.57 | 8.60 | 5.95 | 6.09 | 7.54 | 5.72 | 8.16 | 7.58 | 7.60 | 6.98 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.08 | 1.08 | 1.26 | 1.30 | 1.30 | 1.32 | 1.75 | 1.33 | 1.27 | 1.34 | 1.42 |
| Quick Ratio | 0.81 | 0.81 | 0.95 | 0.95 | 0.88 | 0.90 | 1.31 | 1.03 | 0.85 | 0.92 | 0.98 |
| Cash Ratio | 0.12 | 0.12 | 0.26 | 0.21 | 0.14 | 0.10 | 0.43 | 0.03 | 0.03 | 0.06 | 0.11 |
| Asset Turnover | — | 0.65 | 0.70 | 0.70 | 0.66 | 0.60 | 0.65 | 0.60 | 0.73 | 0.69 | 0.72 |
| Inventory Turnover | 5.99 | 5.99 | 6.07 | 6.11 | 4.89 | 5.03 | 5.36 | 6.50 | 5.57 | 5.54 | 5.19 |
| Days Sales Outstanding | — | 81.63 | 70.22 | 71.98 | 74.15 | 75.38 | 75.61 | 72.32 | 66.25 | 67.84 | 67.88 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.0% | 1.0% | 1.0% | 1.1% | 1.4% | 0.8% | 0.9% | 1.0% | 1.2% | 1.1% | 1.2% |
| Payout Ratio | 36.3% | 36.3% | 31.4% | 45.0% | 55.2% | 50.1% | — | 35.5% | 34.7% | 29.8% | 34.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.6% | 2.8% | 3.1% | 2.4% | 2.6% | 1.7% | — | 2.8% | 3.3% | 3.8% | 3.5% |
| FCF Yield | 2.4% | 2.5% | 2.7% | 2.9% | 2.6% | 2.1% | 2.2% | 3.0% | 3.3% | 3.1% | 3.4% |
| Buyback Yield | 1.0% | 1.0% | 1.5% | 0.0% | 1.2% | 0.2% | 0.2% | 0.6% | 1.3% | 1.5% | 2.1% |
| Total Shareholder Yield | 2.0% | 2.1% | 2.5% | 1.1% | 2.7% | 1.0% | 1.1% | 1.6% | 2.5% | 2.7% | 3.4% |
| Shares Outstanding | — | $285M | $287M | $287M | $287M | $289M | $287M | $293M | $293M | $294M | $297M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ECL stock.
Ecolab Inc.'s current P/E ratio is 38.0x. The historical average is 30.8x. This places it at the 90th percentile of its historical range.
Ecolab Inc.'s current EV/EBITDA is 24.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.4x.
Ecolab Inc.'s return on equity (ROE) is 22.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 19.4%.
Based on historical data, Ecolab Inc. is trading at a P/E of 38.0x. This is at the 90th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Ecolab Inc.'s current dividend yield is 0.95% with a payout ratio of 36.3%.
Ecolab Inc. has 44.5% gross margin and 18.1% operating margin. Operating margin between 10-20% is typical for established companies.
Ecolab Inc.'s Debt/EBITDA ratio is 2.6x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Execution risk on raised guidance
Metrics are mathematically derived from official filings.
Premium Multiple Reflects Recurring Model
ECL trades at 38.7x trailing P/E and 24.6x EV/EBITDA, per reported multiples, a premium to specialty chemical peers like RPM and CHD, suggesting the market prices in durable growth and service-like recurring revenue.
The forward P/E of 34.5x implies the market expects continued earnings acceleration, consistent with the recent guidance raise. However, the EV/EBITDA premium over peers (e.g., RPM at 17.0x) may be justified by higher gross margins and a more defensive revenue mix, but it leaves little room for disappointment. Investors should monitor whether the multiple compresses if organic growth decelerates.
Margin Resilience Amid Mix Shifts
Gross margin held near 44% over the past year, with 2026Q2 at 44.1%, as reported in financial statements, while operating margin expanded to 17.2% from 15.3% sequentially, indicating pricing power and cost discipline despite Ovivo drag.
The stability of gross margin despite raw material volatility suggests successful price-to-value realization. Operating margin improvement in 2026Q2, driven by flat SG&A, points to operating leverage. However, the Ovivo Electronics segment appears to be a margin drag, as management explicitly carved it out, and its contribution warrants close scrutiny.
ROIC Recovery Tempered by Acquisition
ROIC improved to 3.0% in 2026Q2 from 2.5% in 2026Q1, as per reported figures, but remains below the 3.4% peak in 2025Q3, reflecting the dilutive impact of the Ovivo acquisition and elevated capital base.
The sequential improvement in ROIC suggests operational recovery, but the 40% surge in total assets from the debt-funded acquisition has temporarily depressed returns. ROE also remains modest at 5.3%, well below peers like SHW (62.1%), indicating that Ecolab's capital intensity and service model yield lower returns on equity. The key driver will be whether the acquired assets can be integrated to achieve returns above cost of capital.
Working Capital Efficiency Shows Mixed Signals
Cash conversion cycle improved to 55 days in 2026Q2 from 59 days in 2026Q1, as per reported data, driven by faster collections (DSO down to 73) and extended payables (DPO up to 78), though inventory days remain elevated.
The improvement in CCC is a positive sign, but DSO of 73 days is still high relative to historical levels, suggesting potential collection challenges or customer mix shifts. DPO extension to 78 days indicates increased supplier leverage, which may not be sustainable. Asset turnover remains low at 0.16, reflecting the heavy service equipment base, a structural characteristic of the business model.
Leverage Jumps on Acquisition, Coverage Still Adequate
Debt-to-equity rose to 1.36 in 2026Q2 from 0.92 in 2026Q1, as per financial statements, reflecting a $4.5B debt-funded acquisition, while interest coverage of 10.5x remains comfortable but down from 12.5x in 2024Q3.
The sharp increase in leverage is a direct result of the Ovivo acquisition, and while interest coverage remains adequate, the higher debt load reduces financial flexibility. The D/EBITDA of 17.9x is elevated, but this may be distorted by the acquisition timing; investors should monitor deleveraging progress. The balance sheet retains some capacity, but large-scale M&A may require equity issuance.
Liquidity Strengthens with Cash Infusion
Current ratio improved to 1.84 in 2026Q2 from 0.99 in 2026Q1, as per reported data, with cash surging to $5.1B, providing a strong buffer against short-term obligations and supporting working capital needs.
The liquidity position is now robust, but the improvement is partly due to debt proceeds from the acquisition, not organic cash generation. The quick ratio of 1.57 indicates that inventory is not a major liquidity concern. However, the elevated cash balance may be earmarked for integration costs or debt repayment, so investors should assess the sustainability of this liquidity without relying on further debt issuance.
Premium Valuation vs. Specialty Peers
ECL's P/E of 38.7x and EV/EBITDA of 24.6x, per reported multiples, are higher than RPM (21.3x P/E) and CHD (32.3x P/E), reflecting its defensive growth profile and service model, but the gap may narrow if growth disappoints.
Compared to peers, Ecolab's net margin of 12.1% is above RPM's 8.4% and CHD's 11.9%, supporting a premium. However, its ROE of 5.3% is far below SHW's 62.1%, indicating that the market is paying for stability and recurring revenue rather than high returns. The valuation gap appears structural, given Ecolab's higher service intensity and data-driven moat, but it leaves limited margin of safety.
Misapplied Metric: P/E on Cyclical Earnings
The P/E ratio is commonly misapplied to Ecolab because its earnings are subject to one-off items and acquisition-related charges, as seen in the recent EPS miss, obscuring underlying earning power.
Investors should use EV/EBITDA or normalized earnings, adjusting for restructuring and acquisition costs, to better capture the recurring service revenue. The trailing P/E of 38.7x may overstate expensiveness if the Ovivo acquisition depresses current earnings. A more appropriate metric is EV/EBITDA, which at 24.6x still reflects a premium but accounts for the capital structure and non-cash charges.